Endocannabinoid/cannabinoid receptor signaling acts centrally and peripherally to govern appetite and energy balance. While system stimulation promotes eating and energy storage, receptor blockade can reduce food intake and facilitate weight loss. In this issue of Cell Metabolism, Addy et al. (2008) test the therapeutic antiobesity potential of taranabant, a cannabinoid 1 receptor inverse agonist
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Cannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy. However,...
SummaryCannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy. H...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
Obesity has been described as a global epidemic. Its increasing prevalence is matched by growing cos...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
Maintenance of body weight is fundamental to maintain one’s health and to promote longevity. N...
Maintenance of body weight is fundamental to maintain one’s health and to promote longevity. N...
The endocannabinoid system elicits multiple physiologic functions that are not fully understood. Ant...
Growing evidence suggests that pathological overactivation of the endocannabinoid system (ECS) is as...
Growing evidence suggests that pathological overactivation of the endocannabinoid system (ECS) is as...
The cannabinoid 1 (CB1) receptor regulates appetite and body weight; however, unwanted central side ...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Cannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy. However,...
SummaryCannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy. H...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
Obesity has been described as a global epidemic. Its increasing prevalence is matched by growing cos...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
The endocannabinoids are endogenous lipids capable of binding to both cannabinoid receptors (CB) CB1...
Maintenance of body weight is fundamental to maintain one’s health and to promote longevity. N...
Maintenance of body weight is fundamental to maintain one’s health and to promote longevity. N...
The endocannabinoid system elicits multiple physiologic functions that are not fully understood. Ant...
Growing evidence suggests that pathological overactivation of the endocannabinoid system (ECS) is as...
Growing evidence suggests that pathological overactivation of the endocannabinoid system (ECS) is as...
The cannabinoid 1 (CB1) receptor regulates appetite and body weight; however, unwanted central side ...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for t...
DOI
Add to ORKG